<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Allelic imbalances at chromosome 4p have been largely documented in many different <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, loss of heterozygosity (LOH) at 4p15 has been associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> and poor patient outcome, however no target genes in the region have been identified to date </plain></SENT>
<SENT sid="2" pm="."><plain>Since stromal interaction molecule 2 (STIM2) is located at 4p15.2 and has been proposed as a candidate gene for this region in <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> multiforme, we aimed at investigating the role of STIM2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We studied STIM2 transcript expression levels in a collection of xenografted primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> (n = 20) and a well-annotated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> series of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (n = 140) </plain></SENT>
<SENT sid="4" pm="."><plain>We observed an overexpression of STIM2 in 63.5% of the cases that was associated with a less invasive phenotype </plain></SENT>
<SENT sid="5" pm="."><plain>In vitro and in vivo functional studies with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines revealed that overexpression of STIM2 <z:mp ids='MP_0000352'>reduced cell proliferation</z:mp> and <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e>, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Our work presents several lines of evidence indicating that STIM2 overexpression is a frequent trait in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> that results in cell growth suppression, certifying that even in the absence of somatic genetic or epigenetic alterations, recurrent regions of LOH should still be considered a hallmark for the presence of relevant genes for <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>